BLRX

BioLineRx News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
BioLineRx Ltd BLRX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0089 0.39% 2.3189 10:27:08
Open Price Low Price High Price Close Price Previous Close
2.28 2.28 2.38 2.31
more quote information »

Recent News

Date Time Source Heading
12/03/202012:59IHNWFeaturedVinco Ventures, Inc. announces deal with OPTEC International, Inc. and OPTEC Brand Ambassador Dr. Drew Pinsky
12/04/20208:31IHNWFeaturedManganese X Subsidiary and JV Partner Form PureBiotic Air Inc. and  Expand Testing of HVAC Air Purification Delivery System
11/23/202007:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/18/202007:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/13/202016:32EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/03/202016:39EDGARAmended Statement of Ownership (sc 13g/a)
10/30/202007:10EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/25/202016:34EDGARReport of Foreign Issuer (6-k)
9/25/202016:31EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/24/202016:30EDGARReport of Foreign Issuer (6-k)
8/19/202016:34EDGARReport of Foreign Issuer (6-k)
8/19/202007:08EDGARReport of Foreign Issuer (6-k)
8/13/202006:03EDGARNotice of Effectiveness (effect)
8/10/202006:14EDGARPost-effective Amendment to Registration Statement (pos Am)
8/06/202007:48EDGARReport of Foreign Issuer (6-k)
7/06/202006:30EDGARNotice of Effectiveness (effect)
7/02/202017:38EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/26/202016:31EDGARSecurities Registration (foreign Private Issuer) (f-1)
6/10/202008:03EDGARSmall Company Offering and Sale of Securities Without..
6/10/202008:01EDGARSmall Company Offering and Sale of Securities Without..
6/05/202016:17EDGARStatement of Ownership (sc 13g)
6/05/202006:04EDGARStatement of Ownership (sc 13g)
6/05/202006:02EDGARStatement of Ownership (sc 13g)
6/03/202008:34EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/03/202008:30EDGARReport of Foreign Issuer (6-k)
6/02/202006:01EDGARAmended Statement of Ownership (sc 13g/a)
6/01/202008:06EDGARReport of Foreign Issuer (6-k)
5/28/202012:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/28/202011:57EDGARReport of Foreign Issuer (6-k)
5/27/202007:00EDGARReport of Foreign Issuer (6-k)
5/26/202014:54EDGARStatement of Ownership (sc 13g)
5/26/202008:46EDGARReport of Foreign Issuer (6-k)
5/26/202008:10EDGARReport of Foreign Issuer (6-k)
5/20/202007:01EDGARReport of Foreign Issuer (6-k)
4/17/202016:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/23/202016:40EDGARConfidential Treatment Order (ct Order)
3/12/202007:09EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/12/202007:00EDGARReport of Foreign Issuer (6-k)
3/05/202010:00EDGARReport of Foreign Issuer (6-k)
2/27/202007:01EDGARReport of Foreign Issuer (6-k)
2/19/202009:11EDGARConfidential Treatment Order (ct Order)
2/14/202016:03EDGARStatement of Ownership (sc 13g)
See more news about this stock »


Your Recent History
NASDAQ
BLRX
BioLineRx
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.